It all started in 1931 in Iowa when Dr. Ralph Falk and Dr. Donald Baxter launched the Don Baxter Intravenous Products Company. Hillrom’s roots go back to when Bill Hillenbrand revolutionized the hospital bed field in 1929. Dr. Francis Welch and William Noah Allyn introduced the world’s first handheld direct-illuminating ophthalmoscope in 1915. What started in the United States has now spread worldwide. Together, we remain dedicated to saving and sustaining lives. For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Baxter
Unlock to Claim this listing
Add / Modify Company
1.60
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Medical Equipment ManufacturingESG/Ethical Impact
Baxter’s environmental stewardship is vividly apparent in its comprehensive strategies spanning resource efficiency, responsible sourcing, waste reduction initiatives, and innovative eco-friendly packaging solutions, underscoring its commitment to contribute to a healthier planet while advancing medical advancements and fostering an unwavering culture of environmental responsibility that harmonizes seamlessly with its core healthcare mission. Baxter’s approach to stakeholder engagement embodies inclusivity and collaboration, extending its embrace to encompass patients, healthcare professionals, employees, communities, and investors, fostering an environment of open discourse, empathetic listening, and transparent communication that shapes its strategies, aligns with societal aspirations, and underscores its unwavering commitment to advancing healthcare innovation and societal well-being. Baxter’s ESG framework is rooted deeply in robust governance and ethics that epitomize transparency, integrity, and accountability, permeating its decision-making processes through a diverse and experienced board of directors, stringent compliance mechanisms, and ethical conduct that position the company as an exemplary archetype of responsible corporate citizenship and principled leadership within the realm of innovative healthcare solutions. Baxter’s steadfast commitment to innovation and medical excellence serves as the foundation of its ESG sustainability strategy, characterized by its unrelenting pursuit of pioneering healthcare solutions, addressing complex medical challenges, enhancing patient outcomes, and revolutionizing medical science while adhering to the highest clinical and research standards, thereby driving the evolution of healthcare for the betterment of humanity. Baxter’s financial sustainability is intricately interwoven with its holistic ESG imperatives, as its financial growth harmonizes symbiotically with its ability to provide innovative medical solutions that resonate harmoniously with healthcare professionals, patients, and investors alike, who recognize the intrinsic value of responsible innovation and sustainable business practices.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
15267000000.00
Website Traffic
Employee Rating
3.60
Customer Rating
2.50
Company Size
10000+
ESG Risk Rating
3.00